Previous Close | 51.35 |
Open | 53.00 |
Bid | 56.50 |
Ask | 59.05 |
Strike | 130.00 |
Expire Date | 2025-01-17 |
Day's Range | 51.35 - 53.00 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
Besides Wall Street's top -and-bottom-line estimates for Gilead (GILD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.